Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $63.33 USD
Change Today +0.39 / 0.62%
Volume 1.4M
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard F. Pops

Chairman of the Board and Chief Executive Officer, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 157 board members in 10 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Richard F. Pops has been the Chief Executive Officer of Alkermes PLC since September 11, 2009. Mr. Pops founded Genomics Collaborative, Inc. He Co-Founded Sirtris Pharmaceuticals, Inc. He served as the President of Alkermes PLC from September 11, 2009 to September 16, 2011 and previously served as its Chief Executive Officer from February 1991 to April 1, 2007. Prior to Alkermes, he was employed by PaineWebber Development Corporation as a Vice President. He has been ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4


Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

Founder and Director
Director At Large
Former Director
Chairman of the Board and Chief Executive Officer
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
Former Independent Director and Chairman of Compensation Committee
Former Director
Independent Director and Member of Audit Committee


BA 1983
Stanford University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$810,154

Stock Options*

Restricted Stock Awards$537,875
All Other Compensation$12,750
Exercised Options333,750
Exercised Options Value$5,997,265
Exercisable Options2,497,500
Exercisable Options Value$68,104,888
Unexercisable Options918,750
Unexercisable Options Value$17,079,875
Total Value of Options$91,182,027
Total Number of Options3,750,000

Total Compensation*

Total Annual Cash Compensation$2,422,904
Total Short Term Compensation$810,154
Other Long Term Compensation$550,625
Total Calculated Compensation$6,587,779
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $63.33 USD 0.00


David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Thomas W. D'Alonzo Esq., J.D.Chairman, Acting Chief Executive Officer, Acting President, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
Salix Pharmaceuticals Ltd.
Arun Sawhney B.Com., P.G.D.B.M.Chief Executive Officer, Managing Director, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee, Member of Quality & Integrity Committee, Member of Science Committee and Member of Corporate Social Responsibility Committee
Ranbaxy Laboratories Ltd.
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at